My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2021-109A
CBCC
>
Official Documents
>
2020's
>
2021
>
2021-109A
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
11/17/2021 9:44:33 AM
Creation date
11/12/2021 3:36:05 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Addendum
Approved Date
08/17/2021
Control Number
2021-109A
Agenda Item Number
8.M.
Entity Name
RxBenefits, Inc.
Subject
Addendum to Administrative Services Agreement for RxBenefits and
Express Scripts effective January 1, 2021
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5B185859-5943-4C41-90BF-OCE5E90FDADD <br />(01/2021 Version) <br />Term (as described in Article VI(A) of the Agreement) that begins on or after the Addendum <br />Effective Date. <br />[1 -(total discounted AWP ingredient cost (including any retrospective pharmacy <br />payments) but excluding dispensing fees and ancillary charges, and prior to application <br />of Copayments) of applicable Prescription Drug Claims for the annual period divided <br />by total undiscounted AWP ingredient cost (both amounts will be calculated as of the <br />date of adjudication) for the annual period)]. Discounted ingredient cost will be the <br />lesser of MAC (as applicable), U&C or AWP discount. <br />Notwithstanding anything herein to the contrary: (i) a Prescription Drug Claim that <br />processes at the Brand rates (Participating Pharmacy Reimbursement Rates) and (Mail <br />Pharmacy Reimbursement Rates), as indicated on the ingredient cost field of the <br />Prescription Drug Claim's data record, shall be reconciled as part of the Brand <br />guarantee below; and (ii) a Prescription Drug Claim that processes at the Generic Drug <br />rates (Participating Pharmacy Reimbursement Rates) and (Mail Pharmacy <br />Reimbursement Rates) above, as indicated on the ingredient cost field of the <br />Prescription Drug Claim's data record, shall be reconciled as part of the Generic Drug <br />guarantee below. The only Prescription Drug Claims that may be excluded from the <br />reconciliation of the pricing guarantees are as identified in the "Claims Excluded" <br />paragraph below in addition to claims dispensed in Puerto Rico, Guam, Northern <br />Mariana Islands, Virgin Islands, Hawaii, Massachusetts, and Alaska,. All other <br />Prescription Drug Claims may be included in the reconciliation of the guarantees. <br />PARTICIPATING PHARMACY <br />BRAND <br />AWP —19.50% <br />GENERIC <br />MAINTENANCE <br />I AWP — <br />NETWORKRETAIL (84-90 1 <br />84.50% <br />BRAND <br />AWP — <br />22.00% <br />GENERIC <br />MAIL SERVICE PHARMACY <br />AWP — <br />84.50% <br />BRAND <br />AWP — <br />25.00% <br />GENERIC <br />AWP — <br />87.00% <br />Claims Excluded: OTC products (excluding insulin, diabetic strips, and test strips), compounds, U&C claims, <br />Member Submitted Claims, Subrogation Claims, Coordination of Benefit Claims, Exclusive and Limited <br />Distribution Products/Claims, vaccines, Specialty Products (other than specialty guarantee) biosimilar <br />products (other than Specialty Product guarantee, if applicable), long term care pharmacy claims and/or <br />claims with ancillary charges and products filled through in-house or 340b pharmacies (if applicable). <br />(b) Dispensing Fee. ESI will guarantee an average aggregate annual per Prescription Drug Claim <br />dispensing fee on Client utilization to be calculated as follows: <br />[total dispensing fee of applicable Prescription Drug Claims for the annual period <br />divided by total of applicable Prescription Drug Claims for the annual period <br />which will represent the same underlying claims dataset used to calculate the <br />"Ingredient Cost Guarantee" of this Exhibit A]. Dispensing fees will be calculated <br />using the lesser of MAC (as applicable), U&C or AWP discount adjudication <br />methodology. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF EXPRESS SCRIPTS AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.